Acrivon Therapeutics, Inc. Common Stock
Acrivon Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing oncology medicines for the patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder ide…
Biotechnology
US, Watertown [HQ]
Strategy & Leadership
Mergers & Acquisitions Beta
M&As
M&A Deals · Breakdown
Acrivon Therapeutics, Inc. Common Stock has no acquisition track records yet.
M&A Deals · History
Acrivon Therapeutics, Inc. Common Stock has no acquisition track records yet.